The Emerging Roles of Long Noncoding RNA ROR (lincRNA-ROR) and its Possible Mechanisms in Human Cancers

Cellular Physiology and Biochemistry

Volumn 40, Issue 1-2, 2016, Pages 219-229

  Pan, Yan ^a   Li, Chen ^a   Chen, Jing ^a   Zhang, Kai ^a   Chu, Xiaoyuan ^a   Wang, Rui ^a   Chen, Longbang ^a  

^a NANJING UNIVERSITY   (China)

Author keywords

Cancer; Linc ROR; MicroRNA; Non coding RNA; Pathological functions

Indexed keywords

COMPETING ENDOGENOUS RNA; LONG NONCODING RNA ROR; LONG UNTRANSLATED RNA; OCTAMER TRANSCRIPTION FACTOR 4; RNA; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG; HISTONE; LINC-RNA-ROR, HUMAN;

BREAST CANCER; CARCINOGENESIS; COLON CANCER; ENDOMETRIUM CANCER; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION; GLIOMA; HISTONE METHYLATION; HUMAN; INDUCED PLURIPOTENT STEM CELL; LIVER CELL CARCINOMA; MALIGNANT NEOPLASM; NASOPHARYNX CARCINOMA; PANCREAS CANCER; PRIORITY JOURNAL; REVIEW; STRESS; GENETICS; METABOLISM; NEOPLASM; PATHOLOGY; PHYSIOLOGICAL STRESS;

CARCINOGENESIS; EPITHELIAL-MESENCHYMAL TRANSITION; HISTONES; HUMANS; NEOPLASMS; RNA, LONG NONCODING; STRESS, PHYSIOLOGICAL;

EID: 84997354269     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000452539     Document Type: Review

References (95)

1. ENCODE Project Consortium: The ENCODE (ENCyclopedia Of DNA Elements) Project. Science 2004;306:636-640.
2. Taft RJ, Pang KC, Mercer TR, Dinger M, Mattick JS: Non-coding RNAs: regulators of disease. J Pathol 2010;220:126-139.
3. Kaikkonen MU, Lam MT, Glass CK: Non-coding RNAs as regulators of gene expression and epigenetics. Cardiovasc Res 2011;90:430-440.
4. Ambros V: The functions of animal microRNAs. Nature 2004;431:350-355.
5. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004;116:281-297.
6. Iorio MV, Croce CM: MicroRNAs in cancer: small molecules with a huge impact. J Clin Oncol 2009;27:5848-5856.
7. Musilova K, Mraz M: MicroRNAs in B-cell lymphomas: how a complex biology gets more complex. Leukemia 2015; 29:1004-1017.
8. Nielsen BS, Jorgensen S, Fog JU, Sokilde R, Christensen IJ, Hansen U, Brunner N, Baker A, Moller S, Nielsen HJ: High levels of microRNA-21 in the stroma of colorectal cancers predict short disease-free survival in stage II colon cancer patients. Clin Exp Metastasis 2011;28:27-38.
9. Zhang H, Zhu JK: Emerging roles of RNA processing factors in regulating long non-coding RNAs. RNA Biol 2014;11:793-797.
10. St Laurent G, Wahlestedt C, Kapranov P: The Landscape of long noncoding RNA classification. Trends Genet 2015;31:239-251.
11. Li C, Chen J, Zhang K, Feng B, Wang R, Chen L: Progress and Prospects of Long Noncoding RNAs (lncRNAs) in Hepatocellular Carcinoma. Cell Physiol Biochem 2015;36:423-434.
12. Liu HQ, Li Y, Irwin DM, Zhang YP, Wu DD: Integrative analysis of young genes, positively selected genes and lncRNAs in the development of Drosophila melanogaster. BMC Evol Biol 2014;14:241.
13. Reiche K, Kasack K, Schreiber S, Luders T, Due EU, Naume B, Riis M, Kristensen VN, Horn F, Borresen-Dale AL, Hackermuller J, Baumbusch LO: Long non-coding RNAs differentially expressed between normal versus primary breast tumor tissues disclose converse changes to breast cancer-related protein-coding genes. PLoS One 2014;9:e106076.
14. Batista PJ, Chang HY: Long noncoding RNAs: cellular address codes in development and disease. Cell 2013;152:1298-1307.
15. Chen LL, Carmichael GG: Decoding the function of nuclear long non-coding RNAs. Curr Opin Cell Biol 2010;22:357-364.
16. Jalali S, Bhartiya D, Lalwani MK, Sivasubbu S, Scaria V: Systematic transcriptome wide analysis of lncRNA-miRNA interactions. PLoS One 2013;8:e53823.
17. Mercer TR, Mattick JS: Structure and function of long noncoding RNAs in epigenetic regulation. Nat Struct Mol Biol 2013;20:300-307.
18. Tang Q, Ni Z, Cheng Z, Xu J, Yu H, Yin P: Three circulating long non-coding RNAs act as biomarkers for predicting NSCLC. Cell Physiol Biochem 2015;37:1002-1009.
19. Zhou X, Ye F, Yin C, Zhuang Y, Yue G, Zhang G: The Interaction Between MiR-141 and lncRNA-H19 in Regulating Cell Proliferation and Migration in Gastric Cancer. Cell Physiol Biochem 2015;36:1440-1452.
20. Li J, Long W, Li Q, Zhou Q, Wang Y, Wang H, Zhou B, Li J: Distinct expression profiles of lncRNAs between regressive and mature scars. Cell Physiol Biochem 2015;35:663-675.
21. Gutschner T, Diederichs S: The hallmarks of cancer: a long non-coding RNA point of view. RNA Biol 2012;9:703-719.
22. Wu CL, Wang Y, Jin B, Chen H, Xie BS, Mao ZB: Senescence-associated Long Non-coding RNA (SALNR) Delays Oncogene-induced Senescence through NF90 Regulation. J Biol Chem 2015;290:30175-30192.
23. Li J, Wang X, Tang J, Jiang R, Zhang W, Ji J, Sun B: HULC and Linc00152 Act as Novel Biomarkers in Predicting Diagnosis of Hepatocellular Carcinoma. Cell Physiol Biochem 2015;37:687-696.
24. Kladi-Skandali A, Michaelidou K, Scorilas A, Mavridis K: Long Noncoding RNAs in Digestive System Malignancies: A Novel Class of Cancer Biomarkers and Therapeutic Targets?. Gastroenterol Res Pract 2015;2015:319861.
25. Lin R, Maeda S, Liu C, Karin M, Edgington TS: A large noncoding RNA is a marker for murine hepatocellular carcinomas and a spectrum of human carcinomas. Oncogene 2007;26:851-858.
26. Gabory A, Ripoche MA, Le Digarcher A, Watrin F, Ziyyat A, Forne T, Jammes H, Ainscough JF, Surani MA, Journot L, Dandolo L: H19 acts as a trans regulator of the imprinted gene network controlling growth in mice. Development 2009;136:3413-3421.
27. Arima T, Matsuda T, Takagi N, Wake N: Association of IGF2 and H19 imprinting with choriocarcinoma development. Cancer Genet Cytogenet 1997;93:39-47.
28. Gao ZH, Suppola S, Liu J, Heikkila P, Janne J, Voutilainen R: Association of H19 promoter methylation with the expression of H19 and IGF-II genes in adrenocortical tumors. J Clin Endocrinol Metab 2002;87:1170-1176.
29. Loewer S, Cabili MN, Guttman M, Loh YH, Thomas K, Park IH, Garber M, Curran M, Onder T, Agarwal S, Manos PD, Datta S, Lander ES, Schlaeger TM, Daley GQ, Rinn JL: Large intergenic non-coding RNA-RoR modulates reprogramming of human induced pluripotent stem cells. Nat Genet 2010;42:1113-1117.
30. Amaral PP, Clark MB, Gascoigne DK, Dinger ME, Mattick JS: lncRNAdb: a reference database for long noncoding RNAs. Nucleic Acids Res 2011;39:D146-151.
31. Wang Y, Xu Z, Jiang J, Xu C, Kang J, Xiao L, Wu M, Xiong J, Guo X, Liu H: Endogenous miRNA sponge lincRNA-RoR regulates Oct4, Nanog, and Sox2 in human embryonic stem cell self-renewal. Dev Cell 2013;25:69-80.
32. Eades G, Wolfson B, Zhang Y, Li Q, Yao Y, Zhou Q: lincRNA-RoR and miR-145 regulate invasion in triple-negative breast cancer via targeting ARF6. Mol Cancer Res 2015;13:330-338.
33. Chen YM, Liu Y, Wei HY, Lv KZ, Fu P: Linc-ROR induces epithelial-mesenchymal transition and contributes to drug resistance and invasion of breast cancer cells. Tumour Biol 2016;37:10861-10870.
34. Hou P, Zhao Y, Li Z, Yao R, Ma M, Gao Y, Zhao L, Zhang Y, Huang B, Lu J: LincRNA-ROR induces epithelial-to-mesenchymal transition and contributes to breast cancer tumorigenesis and metastasis. Cell Death Dis 2014;5:e1287.
35. Duru N, Gernapudi R, Lo PK, Yao Y, Wolfson B, Zhang Y, Zhou Q: Characterization of the CD49f+/CD44+/CD24-single-cell derived stem cell population in basal-like DCIS cells. Oncotarget DOI:10.18632/oncotarget.10203.
36. Takahashi K, Yan IK, Haga H, Patel T: Modulation of hypoxia-signaling pathways by extracellular linc-RoR. J Cell Sci 2014;127:1585-1594.
37. Takahashi K, Yan IK, Kogure T, Haga H, Patel T: Extracellular vesicle-mediated transfer of long non-coding RNA ROR modulates chemosensitivity in human hepatocellular cancer. FEBS Open Bio 2014;4:458-467.
38. Zhou X, Gao Q, Wang J, Zhang X, Liu K, Duan Z: Linc-RNA-RoR acts as a "sponge" against mediation of the differentiation of endometrial cancer stem cells by microRNA-145. Gynecol Oncol 2014;133:333-339.
39. Rezaei M, Emadi-Baygi M, Hoffmann MJ, Schulz WA, Nikpour P: Altered expression of LINC-ROR in cancer cell lines and tissues. Tumour Biol 2016;37:1763-1769.
40. Feng S, Yao J, Chen Y, Geng P, Zhang H, Ma X, Zhao J, Yu X: Expression and Functional Role of Reprogramming-Related Long Noncoding RNA (lincRNA-ROR) in Glioma. J Mol Neurosci 2015;56:623-630.
41. Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi PP: A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language?. Cell 2011;146:353-358.
42. Friedman RC, Farh KK, Burge CB, Bartel DP: Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 2009;19:92-105.
43. Bartel DP: MicroRNAs: target recognition and regulatory functions. Cell 2009;136:215-233.
44. Cesana M, Cacchiarelli D, Legnini I, Santini T, Sthandier O, Chinappi M, Tramontano A, Bozzoni I: A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell 2011;147:358-369.
45. Hansen TB, Jensen TI, Clausen BH, Bramsen JB, Finsen B, Damgaard CK, Kjems J: Natural RNA circles function as efficient microRNA sponges. Nature 2013;495:384-388.
46. Memczak S, Jens M, Elefsinioti A, Torti F, Krueger J, Rybak A, Maier L, Mackowiak SD, Gregersen LH, Munschauer M, Loewer A, Ziebold U, Landthaler M, Kocks C, le Noble F, Rajewsky N: Circular RNAs are a large class of animal RNAs with regulatory potency. Nature 2013;495:333-338.
47. Tay Y, Kats L, Salmena L, Weiss D, Tan SM, Ala U, Karreth F, Poliseno L, Provero P, Di Cunto F, Lieberman J, Rigoutsos I, Pandolfi PP: Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs. Cell 2011;147:344-357.
48. Gao S, Wang P, Hua Y, Xi H, Meng Z, Liu T, Chen Z, Liu LM: ROR functions as a ceRNA to regulate Nanog expression by sponging miR-145 and predicts poor prognosis in pancreatic cancer. Oncotarget 2016;7:1608-1618.
49. Jiang F, Zhou X, Huang J: Long Non-Coding RNA-ROR Mediates the Reprogramming in Cardiac Hypertrophy. PLoS One 2016;11:e0152767.
50. Looijenga LH, Stoop H, de Leeuw HP, de Gouveia Brazao CA, Gillis AJ, van Roozendaal KE, van Zoelen EJ, Weber RF, Wolffenbuttel KP, van Dekken H, Honecker F, Bokemeyer C, Perlman EJ, Schneider DT, Kononen J, Sauter G, Oosterhuis JW: POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. Cancer Res 2003;63:2244-2250.
51. Rizzino A: Sox2 and Oct-3/4: a versatile pair of master regulators that orchestrate the self-renewal and pluripotency of embryonic stem cells. Wiley Interdiscip Rev Syst Biol Med 2009;1:228-236.
52. Gontan C, de Munck A, Vermeij M, Grosveld F, Tibboel D, Rottier R: Sox2 is important for two crucial processes in lung development: branching morphogenesis and epithelial cell differentiation. Dev Biol 2008;317:296-309.
53. Boyer LA, Lee TI, Cole MF, Johnstone SE, Levine SS, Zucker JP, Guenther MG, Kumar RM, Murray HL, Jenner RG, Gifford DK, Melton DA, Jaenisch R, Young RA: Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 2005;122:947-956.
54. Okita K, Ichisaka T, Yamanaka S: Generation of germline-competent induced pluripotent stem cells. Nature 2007;448:313-317.
55. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R, Slukvin, II, Thomson JA: Induced pluripotent stem cell lines derived from human somatic cells. Science 2007;318:1917-1920.
56. Zou G, Liu T, Guo L, Huang Y, Feng Y, Huang Q, Duan T: miR-145 modulates lncRNA-ROR and Sox2 expression to maintain human amniotic epithelial stem cell pluripotency and beta islet-like cell differentiation efficiency. Gene 2016;591:48-57.
57. Xie H, Wang Y, Zhang H, Qi H, Zhou H, Li FR: Role of injured pancreatic extract promotes bone marrow-derived mesenchymal stem cells efficiently differentiate into insulin-producing cells. PLoS One 2013;8:e76056.
58. Yin DD, Zhang EB, You LH, Wang N, Wang LT, Jin FY, Zhu YN, Cao LH, Yuan QX, De W, Tang W: Downregulation of lncRNA TUG1 affects apoptosis and insulin secretion in mouse pancreatic beta cells. Cell Physiol Biochem 2015;35:1892-1904.
59. Keith B, Johnson RS, Simon MC: HIF1alpha and HIF2alpha: sibling rivalry in hypoxic tumour growth and progression. Nat Rev Cancer 2012;12:9-22.
60. Xiang ZL, Zeng ZC, Fan J, Tang ZY, Zeng HY, Gao DM: Gene expression profiling of fixed tissues identified hypoxia-inducible factor-1alpha, VEGF, and matrix metalloproteinase-2 as biomarkers of lymph node metastasis in hepatocellular carcinoma. Clin Cancer Res 2011;17:5463-5472.
61. Hashimoto S, Onodera Y, Hashimoto A, Tanaka M, Hamaguchi M, Yamada A, Sabe H: Requirement for Arf6 in breast cancer invasive activities. Proc Natl Acad Sci U S A 2004;101:6647-6652.
62. Zhou P, Sun L, Liu D, Liu C, Sun L: Long Non-Coding RNA lincRNA-ROR Promotes the Progression of Colon Cancer and Holds Prognostic Value by Associating with miR-145. Pathol Oncol Res 2016;22:733-740.
63. Liu Y, Zhou D, Li G, Ming X, Tu Y, Tian J, Lu H, Yu B: Long non coding RNA-UCA1 contributes to cardiomyocyte apoptosis by suppression of p27 expression. Cell Physiol Biochem 2015;35:1986-1998.
64. Sarrio D, Rodriguez-Pinilla SM, Hardisson D, Cano A, Moreno-Bueno G, Palacios J: Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype. Cancer Res 2008;68:989-997.
65. Peinado H, Olmeda D, Cano A: Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?. Nat Rev Cancer 2007;7:415-428.
66. Yang J, Weinberg RA: Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell 2008;14:818-829.
67. Zhang W, Feng M, Zheng G, Chen Y, Wang X, Pen B, Yin J, Yu Y, He Z: Chemoresistance to 5-fluorouracil induces epithelial-mesenchymal transition via up-regulation of Snail in MCF7 human breast cancer cells. Biochem Biophys Res Commun 2012;417:679-685.
68. Kajiyama H, Shibata K, Terauchi M, Yamashita M, Ino K, Nawa A, Kikkawa F: Chemoresistance to paclitaxel induces epithelial-mesenchymal transition and enhances metastatic potential for epithelial ovarian carcinoma cells. Int J Oncol 2007;31:277-283.
69. Du F, Wu X, Liu Y, Wang T, Qi X, Mao Y, Jiang L, Zhu Y, Chen Y, Zhu R, Han X, Jin J, Ma X, Hua D: Acquisition of paclitaxel resistance via PI3K dependent epithelial mesenchymal transition in A2780 human ovarian cancer cells. Oncol Rep 2013;30:1113-1118.
70. Zhan HX, Wang Y, Li C, Xu JW, Zhou B, Zhu JK, Han HF, Wang L, Wang YS, Hu SY: LincRNA-ROR promotes invasion, metastasis and tumor growth in pancreatic cancer through activating ZEB1 pathway. Cancer Lett 2016;374:261-271.
71. Wellner U, Schubert J, Burk UC, Schmalhofer O, Zhu F, Sonntag A, Waldvogel B, Vannier C, Darling D, zur Hausen A, Brunton VG, Morton J, Sansom O, Schuler J, Stemmler MP, Herzberger C, Hopt U, Keck T, Brabletz S, Brabletz T: The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nat Cell Biol 2009;11:1487-1495.
72. Levine AJ, Oren M: The first 30 years of p53: growing ever more complex. Nat Rev Cancer 2009;9:749-758.
73. Vousden KH, Prives C: Blinded by the Light: The Growing Complexity of p53. Cell 2009;137:413-431.
74. Zhang A, Zhou N, Huang J, Liu Q, Fukuda K, Ma D, Lu Z, Bai C, Watabe K, Mo YY: The human long non-coding RNA-RoR is a p53 repressor in response to DNA damage. Cell Res 2013;23:340-350.
75. Oberstrass FC, Auweter SD, Erat M, Hargous Y, Henning A, Wenter P, Reymond L, Amir-Ahmady B, Pitsch S, Black DL, Allain FH: Structure of PTB bound to RNA: specific binding and implications for splicing regulation. Science 2005;309:2054-2057.
76. Li L, Gu M, Bo Y, Shi S, Shan Y, Bao L, Yiwen Y: Long non-coding RNA ROR promotes proliferation, migration and chemoresistance of nasopharyngeal carcinoma. Cancer Sci 2016;107:1215-1222.
77. Huang J, Zhang A, Ho TT, Zhang Z, Zhou N, Ding X, Zhang X, Xu M, Mo YY: Linc-RoR promotes c-Myc expression through hnRNP I and AUF1. Nucleic Acids Res 2016;44:3059-3069.
78. Yang ZT, Li Z, Wang XG, Tan T, Yi F, Zhu H, Zhao JP, Zhou XF. Overexpression of Long Non-Coding RNA ZXF2 Promotes Lung Adenocarcinoma Progression Through c-Myc Pathway. Cell Physiol Biochem 2015;35:2360-2370.
79. Yu S, Kong AN: Targeting carcinogen metabolism by dietary cancer preventive compounds. Curr Cancer Drug Targets 2007;7:416-424.
80. Ohtsuji M, Katsuoka F, Kobayashi A, Aburatani H, Hayes JD, Yamamoto M: Nrf1 and Nrf2 play distinct roles in activation of antioxidant response element-dependent genes. J Biol Chem 2008;283:33554-33562.
81. Zhang Y, Xia J, Li Q, Yao Y, Eades G, Gernapudi R, Duru N, Kensler TW, Zhou Q: NRF2/long noncoding RNA ROR signaling regulates mammary stem cell expansion and protects against estrogen genotoxicity. J Biol Chem 2014;289:31310-31318.
82. Chen W, Jiang T, Wang H, Tao S, Lau A, Fang D, Zhang DD: Does Nrf2 contribute to p53-mediated control of cell survival and death?. Antioxid Redox Signal 2012;17:1670-1675.
83. Fan J, Xing Y, Wen X, Jia R, Ni H, He J, Ding X, Pan H, Qian G, Ge S, Hoffman AR, Zhang H, Fan X: Long non-coding RNA ROR decoys gene-specific histone methylation to promote tumorigenesis. Genome Biol 2015;16:275.
84. Kang YH, Han SR, Kim JT, Lee SJ, Yeom YI, Min JK, Lee CH, Kim JW, Yoon SR, Yoon DY, Hong KS, Hwang GS, Kim HC, Lee YH, Lee HG: The EF-hand calcium-binding protein tescalcin is a potential oncotarget in colorectal cancer. Oncotarget 2014;5:2149-2160.
85. Man CH, Lam SS, Sun MK, Chow HC, Gill H, Kwong YL, Leung AY: A novel tescalcin-sodium/hydrogen exchange axis underlying sorafenib resistance in FLT3-ITD+ AML. Blood 2014;123:2530-2539.
86. Wang Y, Li Y, Yang Z, Liu K, Wang D: Genome-Wide Microarray Analysis of Long Non-Coding RNAs in Eutopic Secretory Endometrium with Endometriosis. Cell Physiol Biochem 2015;37:2231-2245.
87. Shi Z, Zhao C, Long W, Ding H, Shen R: Microarray Expression Profile Analysis of Long Non-Coding RNAs in Umbilical Cord Plasma Reveals their Potential Role in Gestational Diabetes-Induced Macrosomia. Cell Physiol Biochem 2015;36:542-554.
88. Wang Y, Gao S, Liu G, Jia R, Fan D, Feng X: Microarray expression profile analysis of long non-coding RNAs in human gastric cardiac adenocarcinoma. Cell Physiol Biochem 2014;33:1225-1238.
89. Zhang Y, Feng Y, Hu Z, Hu X, Yuan CX, Fan Y, Zhang L: Characterization of Long Noncoding RNA-Associated Proteins by RNA-Immunoprecipitation. Methods Mol Biol 2016;1402:19-26.
90. Bai Q, Bai Z, Sun L: Detection of RNA-binding Proteins by In Vitro RNA Pull-down in Adipocyte Culture. J Vis Exp 2016;(113).
91. Dhanasekaran S, Doherty TM, Kenneth J, Group TBTS: Comparison of different standards for real-time PCR-based absolute quantification. J Immunol Methods 2010;354:34-39.
92. Hu X, Feng Y, Hu Z, Zhang Y, Yuan CX, Xu X, Zhang L: Detection of Long Noncoding RNA Expression by Nonradioactive Northern Blots. Methods Mol Biol 2016;1402:177-188.
93. Jin L, Lloyd RV: In situ hybridization: methods and applications. J Clin Lab Anal 1997;11:2-9.
94. Jiang Q, Wang J, Wu X, Ma R, Zhang T, Jin S, Han Z, Tan R, Peng J, Liu G, Li Y, Wang Y: LncRNA2Target: a database for differentially expressed genes after lncRNA knockdown or overexpression. Nucleic Acids Res 2015;43:D193-196.
95. Burnett JC, Rossi JJ: RNA-based therapeutics: current progress and future prospects. Chem Biol 2012;19:60-71.